Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association
Donald Lloyd-Jones et al.
CIRCULATION (2010)
The lipophilic zinc chelator DP-b99 prevents zinc induced neuronal death
Ronit BarKalifa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review
Valery L. Feigin et al.
LANCET NEUROLOGY (2009)
Availability of CT and MR for assessing patients with acute stroke
I. Kane et al.
CEREBROVASCULAR DISEASES (2008)
Baseline NIH Stroke Scale Responses Estimate the Probability of Each Particular Stroke Subtype
E. C. Leira et al.
CEREBROVASCULAR DISEASES (2008)
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 - The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee
Werner Hacke et al.
CEREBROVASCULAR DISEASES (2008)
Characterizing the dose-response relationship between mannitol and intracranial pressure in traumatic brain injury patients using a high-frequency physiological data collection system
Marco D. Sorani et al.
JOURNAL OF NEUROTRAUMA (2008)
Neuroanatomic correlation of the post-stroke aphasias studied with imaging
Zhong-Hua Yang et al.
NEUROLOGICAL RESEARCH (2008)
A critique of SAINT II -: Wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke
Sean I. Savitz et al.
STROKE (2008)
Time spent at home poststroke - Home-Time a meaningful and robust outcome measure for stroke trials
Terence J. Quinn et al.
STROKE (2008)
National US estimates of recombinant tissue plasminogen activator use - ICD-9 codes substantially underestimate
Dawn Kleindorfer et al.
STROKE (2008)
DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke
Hans-Christoph Diener et al.
STROKE (2008)
Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials
Jeffrey L. Saver
STROKE (2007)
Facilities available in European hospitals treating stroke patients
Didier Leys et al.
STROKE (2007)
Perimetric homonymous visual field loss post-stroke
Bradley Scott Townend et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2007)
Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials
Terence J. Quinn et al.
STROKE (2007)
The role of zinc in cerebral ischemia
Sherri L. Galasso et al.
MOLECULAR MEDICINE (2007)
Guidelines for the early management of adults with ischemic stroke - A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups
Harold P. Adams et al.
STROKE (2007)
Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided
Bep Boode et al.
CEREBROVASCULAR DISEASES (2007)
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
Alan D. Lopez et al.
LANCET (2006)
Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator
C. Weimar et al.
CEREBROVASCULAR DISEASES (2006)
Improving patient selection for clinical acute stroke trials
Christian Weimar et al.
CEREBROVASCULAR DISEASES (2006)
Clinical pharmacology of DP-b99 in healthy volunteers: First administration to humans
G Rosenberg et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Cerebral ischemia, matrix metalloproteinases, and TNF-α:: MMP inhibitors may act not exclusively by reducing MMP activity
M Dittmar et al.
STROKE (2004)
Metal ion chelation in neurodegenerative disorders
I Angel et al.
DRUG DEVELOPMENT RESEARCH (2002)
Correlation of aphasia and/or neglect with cortical infarction in a subpopulation of RANTTAS
BB Worrall et al.
CEREBROVASCULAR DISEASES (2001)
Share Paper
